0,558  0,017  Antineoplastic (melanoma)
0,537  0,040  Antineoplastic (solid tumors)
0,456  0,019  Antineoplastic (glioblastoma multiforme)
0,445  0,028  Antineoplastic (glioma)
0,426  0,019  Antineoplastic (renal cancer)
0,458  0,056  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,417  0,054  GABA C receptor rho-3 antagonist
0,369  0,039  Antineoplastic (non-small cell lung cancer)
0,350  0,057  CYP2D6 substrate
0,335  0,043  Ca2+/calmodulin-dependent kinase II alpha inhibitor
0,396  0,113  Caspase 9 stimulant
0,303  0,032  Sedative
0,325  0,065  Antineoplastic (ovarian cancer)
0,304  0,050  Cardiovascular analeptic
0,255  0,006  Aldehyde dehydrogenase substrate
0,293  0,045  Psychostimulant
0,259  0,018  Aldehyde oxidase substrate
0,308  0,080  Apoptosis antagonist
0,289  0,071  FMO3 substrate
0,232  0,019  DNA intercalator
0,280  0,068  Transcription factor STAT inhibitor
0,237  0,033  Cytidine deaminase inhibitor
0,196  0,013  Protein kinase C mu inhibitor
0,199  0,018  GABA receptor agonist
0,286  0,108  CYP3A4 substrate
0,272  0,098  Prostate cancer treatment
0,249  0,081  DNA damaging
0,236  0,082  Tyrosine 3 hydroxylase inhibitor
0,199  0,047  Protein kinase C nu inhibitor
0,186  0,037  GABA C receptor rho-2 antagonist
0,230  0,083  DNA synthesis inhibitor
0,238  0,093  Transcription factor STAT3 inhibitor
0,247  0,102  GST M1-1 substrate
0,171  0,034  Topoisomerase I inhibitor
0,256  0,123  Vasodilator, peripheral
0,138  0,006  Transforming growth factor beta 3 antagonist
0,292  0,164  Calcium channel L-type activator
0,228  0,100  Ca2+/calmodulin-dependent kinase IV inhibitor
0,168  0,049  SULT1A3 substrate
0,229  0,125  Antifungal
0,189  0,085  Pneumotoxic
0,143  0,039  5 Hydroxytryptamine 3A agonist
0,142  0,039  Alcohol dehydrogenase substrate
0,140  0,038  Butyrylcholinesterase inhibitor
0,203  0,103  Aldehyde oxidase inhibitor
0,106  0,007  Glucosylceramidase inhibitor
0,151  0,056  Interleukin 1 antagonist
0,208  0,114  5 Hydroxytryptamine release stimulant
0,128  0,034  GABA C receptor rho-1 antagonist
0,202  0,116  MAP kinase kinase 3 inhibitor
0,126  0,042  Neutropenia treatment
0,137  0,052  Antiprotozoal (Amoeba)
0,148  0,064  CNS active muscle relaxant
0,108  0,025  mTOR complex 2 inhibitor
0,128  0,045  GABA C receptor antagonist
0,215  0,134  CYP1A2 substrate
0,181  0,103  5 Hydroxytryptamine 3E antagonist
0,139  0,062  Alpha-N-acetylglucosaminidase inhibitor
0,114  0,037  Protein kinase C zeta inhibitor
0,138  0,062  Antiprotozoal (Trichomonas)
0,094  0,019  MAP kinase kinase 7 inhibitor
0,229  0,155  Vasodilator, coronary
0,190  0,117  MAP-kinase-activated kinase 5 inhibitor
0,149  0,078  UGT2B9 substrate
0,174  0,104  Cardiodepressant
0,126  0,056  Antiviral (Influenza B)
0,147  0,077  Acetylcholine M1 receptor antagonist
0,073  0,004  Guanylate cyclase inhibitor
0,085  0,018  Cyclin-dependent kinase 6 inhibitor
0,088  0,021  Plasminogen activator inhibitor
0,174  0,111  Antiparkinsonian, rigidity relieving
0,144  0,082  Cholinergic
0,251  0,189  MAP kinase kinase 6 inhibitor
0,104  0,043  Histamine N-methyltransferase inhibitor
0,196  0,136  Flavin-containing monooxygenase substrate
0,114  0,054  GABA C receptor agonist
0,084  0,025  Protein kinase C beta inhibitor
0,137  0,079  Skeletal muscle relaxant
0,229  0,173  Calcium channel activator
0,081  0,027  Gaucher disease treatment
0,145  0,092  Uterine stimulant
0,125  0,074  Acetylcholinesterase inhibitor
0,164  0,113  Anticonvulsant
0,157  0,107  Anesthetic general
0,126  0,076  Antihemorrhagic
0,103  0,054  Antineoplastic, alkylator
0,176  0,127  Cytostatic
0,190  0,143  CYP2C19 substrate
0,096  0,049  NADH dehydrogenase inhibitor
0,105  0,059  Bronchodilator
0,107  0,062  Carcinogenic, group 2B
0,109  0,064  Protein kinase C gamma inhibitor
0,215  0,174  FMO1 substrate
0,080  0,039  Benzodiazepine agonist
0,099  0,059  Electrolyte absorption antagonist
0,108  0,068  SULT1A1 substrate
0,043  0,004  1,3-Beta-glucan synthase inhibitor
0,066  0,029  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,097  0,061  Interleukin 1 beta converting enzyme inhibitor
0,087  0,053  GABA A receptor agonist
0,144  0,112  UGT2B10 substrate
0,214  0,182  CYP2C9 substrate
0,059  0,028  Plasmin inhibitor
0,042  0,012  Tryptophan 5 hydroxylase inhibitor
0,087  0,057  Granulocyte macrophage colony stimulating factor agonist
0,102  0,072  Excitatory amino acid transporter EAAC1 inhibitor
0,133  0,104  Ca2+-transporting ATPase inhibitor
0,067  0,039  5 Hydroxytryptamine 3 agonist
0,206  0,179  GST A substrate
0,161  0,135  Antineoplastic enhancer
0,086  0,060  Sodium/hydrogen exchanger 5 inhibitor
0,059  0,035  Protein kinase C eta inhibitor
0,157  0,133  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,095  0,073  NAT2 substrate
0,078  0,057  Chymotrypsin inhibitor
0,105  0,084  Acetylcholine muscarinic antagonist
0,217  0,197  Antineoplastic (non-Hodgkin's lymphoma)
0,111  0,093  Antismoking
0,128  0,111  Muscle relaxant
0,054  0,036  Alpha-mannosidase inhibitor
0,104  0,088  Antiprotozoal (Babesia)
0,125  0,110  Hexokinase inhibitor
0,026  0,013  Alpha 1a adrenoreceptor agonist
0,169  0,156  Antihypotensive
0,085  0,073  Restless leg syndrome treatment
0,049  0,037  Alpha 1b adrenoreceptor agonist
0,076  0,065  Antidote, organophosphates
0,245  0,236  5 Hydroxytryptamine release inhibitor
0,084  0,075  Prolactin inhibitor
0,078  0,070  Antiviral (Dengue virus)
0,043  0,035  Mannosidase inhibitor
0,091  0,084  Adenylate kinase inhibitor
0,136  0,129  UDP-glucuronosyltransferase substrate
0,130  0,124  Carcinogenic, group 1
0,166  0,159  Radioprotector
0,092  0,086  Endometrios treatment
0,127  0,123  MAP kinase kinase 4 inhibitor
0,118  0,117  UGT1A3 substrate
0,079  0,078  Antischistosomal
0,053  0,052  Carbamoyl phosphate synthetase inhibitor
0,019  0,018  Adenosine kinase inhibitor

